JD Supra September 20, 2021
McDermott Will & Emery

Today’s global healthcare marketplace is marked by unprecedented transformation. The seismic shifts in healthcare delivery and drug development during COVID-19 have, in 2021, continued to demonstrate the power and capacity for changes in the market. A deep understanding of future regulatory and political risks is more important than ever. Within this dynamic environment, McDermott’s international health lawyers are passionate about our role in shaping the alliances that will lead to next-generation digital health technologies, new pharmaceuticals and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Investments, Pharma, Pharma / Biotech, Provider, Regulations, Survey / Study, Technology, Trends
Owlstone secures $6.5M for breath-based diagnostics for infectious disease
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
Zephyr AI Raises $111 Million in Series A Financing
Private equity pushes wave of healthcare bankruptcies
What 2024 Valley titans want (and get wrong)

Share This Article